Paper32550990
Structure-Guided Optimization of Replication Protein A (RPA)-DNA Interaction Inhibitors.
Gavande NS and 5 others. ACS Med Chem Lett, 2020. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Structure-Guided Optimization of Replication Protein A (RPA)-DNA Interaction Inhibitors. Papers, record 32550990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32550990
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28933851 | Design and Structure-Guided Development of Novel Inhibitors of the Xeroderma Pigmentosum Group A (XPA) Protein-DNA Interaction. | J Med Chem | 2017 | https://conductscience.org/library/papers/28933851 | PubMed |
| 2 | 30108742 | Recent advancements in the discovery of protein-protein interaction inhibitors of replication protein A. | Medchemcomm | 2017 | https://conductscience.org/library/papers/30108742 | PubMed |
| 3 | 23914285 | Discovery of Protein-Protein Interaction Inhibitors of Replication Protein A. | ACS Med Chem Lett | 2013 | https://conductscience.org/library/papers/23914285 | PubMed |
| 4 | 25070753 | RPA inhibition increases replication stress and suppresses tumor growth. | Cancer Res | 2014 | https://conductscience.org/library/papers/25070753 | PubMed |
| 5 | 10329699 | Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10329699 | PubMed |
| 6 | 25449597 | Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer. | Biochem Pharmacol | 2015 | https://conductscience.org/library/papers/25449597 | PubMed |
| 7 | 23070815 | Structure and conformational change of a replication protein A heterotrimer bound to ssDNA. | Genes Dev | 2012 | https://conductscience.org/library/papers/23070815 | PubMed |
| 8 | 21846830 | Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin. | Mol Cancer Ther | 2011 | https://conductscience.org/library/papers/21846830 | PubMed |
| 9 | 24484288 | Targeting DNA damage response in cancer therapy. | Cancer Sci | 2014 | https://conductscience.org/library/papers/24484288 | PubMed |
| 10 | 24491171 | Discovery of a potent stapled helix peptide that binds to the 70N domain of replication protein A. | J Med Chem | 2014 | https://conductscience.org/library/papers/24491171 | PubMed |
| 11 | 15078981 | Development of a high-throughput screen for inhibitors of replication protein A and its role in nucleotide excision repair. | Mol Cancer Ther | 2004 | https://conductscience.org/library/papers/15078981 | PubMed |
| 12 | 24795863 | Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising. | Front Oncol | 2014 | https://conductscience.org/library/papers/24795863 | PubMed |
| 13 | 26748787 | Identification and Optimization of Anthranilic Acid Based Inhibitors of Replication Protein A. | ChemMedChem | 2016 | https://conductscience.org/library/papers/26748787 | PubMed |
| 14 | 26967507 | Structure Property Relationships of Carboxylic Acid Isosteres. | J Med Chem | 2016 | https://conductscience.org/library/papers/26967507 | PubMed |
| 15 | 15279788 | Replication protein A phosphorylation and the cellular response to DNA damage. | DNA Repair (Amst) | 2004 | https://conductscience.org/library/papers/15279788 | PubMed |
| 16 | 28622525 | ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response. | Mol Cell | 2017 | https://conductscience.org/library/papers/28622525 | PubMed |
| 17 | 23962067 | Surface reengineering of RPA70N enables cocrystallization with an inhibitor of the replication protein A interaction motif of ATR interacting protein. | Biochemistry | 2013 | https://conductscience.org/library/papers/23962067 | PubMed |
| 18 | 23708066 | Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. | Cancer J | 2013 | https://conductscience.org/library/papers/23708066 | PubMed |
| 19 | 11157767 | Structure of the major single-stranded DNA-binding domain of replication protein A suggests a dynamic mechanism for DNA binding. | EMBO J | 2001 | https://conductscience.org/library/papers/11157767 | PubMed |
| 20 | 27257245 | DNA REPAIR. Drugging DNA repair. | Science | 2016 | https://conductscience.org/library/papers/27257245 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42465397 | Re-establishment of TAD boundary organization during DNA replication. | bioRxiv | 2026 | https://conductscience.org/library/papers/42465397 | PubMed |
| 42049240 | Replication protein A protects lagging strand gaps, restricting PARP inhibitor-induced synthetic lethality in BRCA1-deficient tumors. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42049240 | PubMed |
| 40339280 | Targeting DNA damage sensors for cancer therapy. | DNA Repair (Amst) | 2025 | https://conductscience.org/library/papers/40339280 | PubMed |
| 39524752 | Multi-omics analysis revealed significant metabolic changes in brain cancer cells treated with paclitaxel and/or topotecan. | Heliyon | 2024 | https://conductscience.org/library/papers/39524752 | PubMed |
| 39187637 | The effect of replication protein A inhibition and post-translational modification on ATR kinase signaling. | Sci Rep | 2024 | https://conductscience.org/library/papers/39187637 | PubMed |
| 37998004 | An Exploration of Small Molecules That Bind Human Single-Stranded DNA Binding Protein 1. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37998004 | PubMed |
| 37474515 | Identification of a small-molecule inhibitor that selectively blocks DNA-binding by Trypanosoma brucei replication protein A1. | Nat Commun | 2023 | https://conductscience.org/library/papers/37474515 | PubMed |
| 37062547 | Cellular resistance mechanisms in cancer and the new approaches to overcome resistance mechanisms chemotherapy. | Saudi Med J | 2023 | https://conductscience.org/library/papers/37062547 | PubMed |
| 36644397 | ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe. | NAR Cancer | 2023 | https://conductscience.org/library/papers/36644397 | PubMed |
| 36203968 | Nucleases and Co-Factors in DNA Replication Stress Responses. | DNA (Basel) | 2022 | https://conductscience.org/library/papers/36203968 | PubMed |
| 35463312 | Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair. | Front Oncol | 2022 | https://conductscience.org/library/papers/35463312 | PubMed |
| 35251993 | In Vivo Targeting Replication Protein A for Cancer Therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/35251993 | PubMed |
| 34283091 | OB-Folds and Genome Maintenance: Targeting Protein-DNA Interactions for Cancer Therapy. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34283091 | PubMed |
| 34238917 | DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34238917 | PubMed |
| 34216544 | Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency. | Mol Cell | 2021 | https://conductscience.org/library/papers/34216544 | PubMed |
| 33119767 | Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku-DNA interaction. | Nucleic Acids Res | 2020 | https://conductscience.org/library/papers/33119767 | PubMed |
| 33043007 | Roles of OB-Fold Proteins in Replication Stress. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33043007 | PubMed |
| 32801161 | Platinum-Induced Ubiquitination of Phosphorylated H2AX by RING1A Is Mediated by Replication Protein A in Ovarian Cancer. | Mol Cancer Res | 2020 | https://conductscience.org/library/papers/32801161 | PubMed |
| 32370233 | Mechanisms of Multidrug Resistance in Cancer Chemotherapy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32370233 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RPA1 | 6117 | PubTator's text mining | https://conductscience.org/library/genes/6117 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32550990
GET https://conductscience.org/api/papers/v1/32550990/references?page=2